Emerging evidence suggests that natural killer (NK) cells (4–6) and regulatory T cells (Tregs, CD4+) (7) play major, protective immune-modulatory roles in both preclinical and human PAH, and associated right ventricular dysfunction (RVD). This evidence concerns the gene CD4 and pulmonary arterial hypertension.